Mycobacterium leprae grows to enormous numbers in the nulnu mouse footpad, producing granulomas resembling those of lepromatous leprosy in humans. Footpad granuloma cells gorged with M. leprae were established in primary cell culture to examine their functional capabilities. These cells were classified as macrophages by the following criteria: positive staining for nonspecific esterase, reduction of Nitro Blue Tetrazolium during phagocytosis of Candida albicans, possession of Fc receptors, and possession of Mac-l antigen. Footpad macrophages also phagocytized and supported the intracellular growth of Toxoplasma gondii. However, unlike peritoneal macrophages, footpad macrophages could not be activated to kill or inhibit T. gondii by macrophage-activing factor produced by mitogen-stimulated spleen cells or by recombinant gamma interferon. Thus, although the lepromatous macrophages appeared to be normal in many of their functions, they were defective in response to macrophage-activating signals.
Mycobacterium leprae is an obligate intracellular pathogen which resides chiefly within cells of the mononuclear phagocyte system. In the skin of lepromatous leprosy patients, large granulomas comprising heavily infected macrophages are evidence of the prolific growth of M. leprae. Thus, although the underlying mechanism(s) of defective cell-mediated immunity in leprosy is not clearly understood (7, 11 ; B. Bloom, Editorial, J. Immunol. 137:i-x, 1986), the failure of the macrophage to kill or inhibit M. leprae is a conspicuous characteristic of the lepromatous form of the disease. It therefore seems apparent that the ability of the macrophage to cope with M. leprae is an issue central to an understanding of the mechanisms of host resistance to the leprosy bacillus.
Multiplication of M. leprae in the footpads of conventional mice represents a means of quantitating the growth of M. leprae isolates (23) but is a poor animal model for the human disease. However, in footpads of athymic (nulnu) mice, M. leprae replicates extensively, producing large granulomas that resemble those of lepromatous leprosy in humans (3) . In the present study, cells from the footpad granulomas of M. leprae-infected nu/nu mice were isolated in primary culture, characterized, and tested for their capacity to respond to the lymphokines macrophage-activating factor (MAF) and recombinant gamma interferon (IFN--y).
MATERIALS AND METHODS Mice. HSD nulnu mice and nul+ + littermates were obtained from Harlan Sprague-Dawley, Indianapolis, Ind. The nulnu mice used had been inoculated with 106 M. leprae cells in the hind footpad 12 to 14 months previously. BALB/c mice were locally bred.
Cell culture. (i) Peritoneal macrophages. Resident peritoneal cells were harvested as described previously (13 (ii) Footpad macrophages. To harvest M. leprae-infected footpad macrophages from nulnu mice, the enlarged footpad was scrubbed with Betadine, dipped in ether, and removed. The granuloma was digested enzymatically by a modification of the technique described by Russell and McIntosh (21) . Briefly, the epidermis of the footpad was aseptically removed, and the remaining footpad tissue was gently minced with sharp scalpels in Hanks balanced salt solution (GIBCO). The footpad cells were dispersed by treatment with collagenase (15 U/ml; Cappel-Worthington Biochemicals, Malvern, Pa.), and DNase (25 p,g/ml; CalbiochemBehring, La Jolla, Calif.) in 10 ml of RPMI 1640-0% FCS. Dispersion was performed at 37°C for 1 h and was repeated twice with fresh enzyme solutions. The cell suspensions produced by each digestion were washed in Hanks balanced salt solution and held at 4°C. Pooled cell suspensions (6.0 ml) were layered on 6.0 ml of Nycodenz (Accurate Chemical and Scientific Corp., Westbury, N.Y.) and centrifuged at 300 x g for 25 min. A band of cells (>95% viable) distinct from the debris at the tube bottom was removed from the Nycodenz gradient and washed three times in Hanks balanced salt solution. The cells were suspended in RPMI 1640-20% FCS at 2 x 106/ml, and 0.5 ml was plated on LUX cover slips in 24-well plates. After 2 h, nonadherent cells were removed by washing and the adherent cells were cultured in RPMI 1640-20% FCS.
(iii) Cell viability. The viability of cells isolated from the footpad granulomas was tested by using the ethidium bromide-acridine orange stain described by Parks et al. (20) . Macrophage phenotypic markers. (i) Nonspecific esterase stain. Monolayers were examined for nonspecific esterase activity by using alpha-naphthol butyrate as the substrate and the procedures described by Koski et al. (12) .
(ii) MAC-1. Monoclonal antibody to MAC-1, a surface macrophage marker (9), was obtained from Boehringer Mannheim Biochemicals (Indianapolis, Ind.). Cell monolayers were fixed briefly in 2% Formalin, washed in phosphatebuffered saline (PBS), and incubated for 30 min at 37°C in MAC-1 antibody diluted 1:10 in PBS. Control serum consisted of supernatant medium from NS-1 hybridoma cells. Binding of MAC-1 antibody was visualized by using an avidin-biotin complex goat anti-mouse immunoglobulin G (IgG) kit (Vector Labs, Inc., Burlingame, Calif.).
(iii) Phagocytosis and NBT reduction. Heat-killed Candida albicans cells were suspended in RPMI 1640-20% FCS containing 0.2 mg of Nitro Blue Tetrazolium (NBT) (Sigma) per ml and used to challenge peritoneal and footpad monolayers at a ratio of two yeast cells per macrophage.
After 30 min, extracellular yeast cells were rinsed off and the monolayers were fixed in 50% methanol, counterstained with 2% safranin, and examined for intracellular formazan precipitate indicative of NBT reduction.
(iv) Fc receptors. Sheep erythrocytes (SRBC) were coated with a 1:100 dilution (in PBS) of rabbit anti-SRBC IgG (Cappel-Worthington), incubated 1 h at 37°C, and washed three times in PBS. IgG-coated SRBC and normal SRBC were incubated with mouse peritoneal macrophage and footpad macrophage monolayers for 30 min at room temperature. Nonadherent cells were removed by extensive rinsing in PBS, and the cover slips were stained with hematoxylin and eosin and examined for Fc rosette formation.
(v) Trypsin removal. Adherent footpad cells and, in certain experiments, peritoneal macrophages were washed and treated for 10 min with 0.05% trypsin (three-times crystallized; Cappel-Worthington).
Lymphokine activation and Toxoplasma gondii microbicidal assay. Live T. gondii RH tachyzoites were freshly harvested from peritoneal cavities of 2-day-infected mice and purified by filtration through 3-,uM polycarbonate membranes (Nuclepore Corp., Pleasanton, Calif.).
MAF was produced from BALB/c mouse spleen cell cultures stimulated with concanavalin A for 48 h at 37°C as previously described (24) . Control MAF was produced from cultures of unstimulated spleen cells. Recombinant murine IFN-y (Mu IFN-y) was obtained from H. M. Shepard, Genentech Inc., South San Francisco, Calif.
Activation of peritoneal or footpad macrophages was evaluated by measurement of the capability of MAF or Mu IFN-y to induce an enhanced microbicidal capacity for T. gondii. Macrophages cultured on LUX cover slips were incubated with MAF or control MAF diluted 1:4 or with various dilutions of Mu IFN-y in RPMI 1640-20% FCS. All lymphokine preparations also included 2 ng of endotoxin (Escherichia coli O111:B4; Sigma) per ml. After 18 h of stimulation, this medium was removed and cell monolayers were challenged with T. gondii, as previously described (24 (Fig. 2B) . In contrast to peritoneal macrophages, footpad granuloma macrophages were not activated by similar doses of MAF and the growth of T. gondii was unrestricted in these cells ( Fig. 2A and B) . To further evaluate the dose required for and the kinetics of the activation response of macrophages, recombinant Mu IFN--y was used rather than MAF. In the experiments for which results are shown in Fig. 3 , a broad dose range of Mu IFN--y was used. A threshold dose of 125 U of Mu IFN--y was required to achieve significant activation of normal peritoneal macrophages (Fig. 3A and B) . In contrast, activation was not observed in footpad granuloma macrophages at doses of Mu IFN--y which greatly exceeded 125 U (Fig. 3A  and B) . Failure of footpad granuloma macrophages to become activated was also observed when Mu IFN--y incubation was extended to 72 h before challenge with T. gondii ( Table 2 ). The inability of footpad granuloma macrophages to respond to lymphokines was not a consequence of the enzyme digestion procedures since monolayers of peritoneal macrophages treated for 1 h with collagenase and DNase were readily activated to kill T. gondii by Mu IFN--y (data included with that for control macrophages in Fig. 2 and 3 ).
DISCUSSION
Our studies of mouse lepromatous granuloma macrophages should prove relevant to an understanding of the lack of host response to M. leprae in lepromatous leprosy. That the lepromatous macrophage is unable to control the intracellular growth of M. Ieprae is clearly evident. Most theories about defective cell-mediated immunity in lepromatous leprosy are concerned with the failure of the specifically sensitized T cell to respond to M. Ieprae antigens (7, 14, 16; INFECT. IMMUN. Bloom, Editorial) rather than the inability of the macrophage to perform its effector function. Postulated roles for defective macrophage function in leprosy have usually been concerned with the failure to process and present antigen (8, 17) .
In this report, we describe the isolation of footpad granuloma macrophages that were tightly adherent and had the capacity to phagocytize, reduce NBT, and retain macrophage characteristics, including Fc receptors. The strong reactivity of these footpad granuloma macrophages with the universal macrophage monoclonal antibody marker MAC-1, suggests that they also possess characteristic C3BI receptors (9) . Over the 2 months that these granuloma cells were isolated and cultured, these characteristics remained unchanged, in contrast to the heterogeneous granuloma cells described by Amsden and Baros (1) . Others A number of studies have concluded that there is no intrinsic defect in the microbicidal capacity of macrophages from leprosy patients (6, 10, 11) . However, these studies were performed with peripheral blood monocytes and did not examine tissue mnacrophages from the lepromatous granuloma. An exception to these findings is the recent work of Nathan et al. (19) , who reported that the monocytes from lepromatous patients were deficient in their ability to release hydrogen peroxide, an important microbicidal component in the respiratory oxidative burst. Interestingly, this blood monocyte defect was restored within a few days after intradermal injection of human IFN-y into lepromatous lesions. Moreover, preliminary observations suggested that local IFN--y treatment also resulted in detectable clearance of bacilli from the lesion. In previous in vivo human studies, Convit et al. (4, 5) showed that intradermal injection of a mixture of Mycobacterium bovis and killed M. leprae cells resulted in the development of a local epithelioid granuloma in lepromatous patients and the elimination of leprosy bacilli from the site. Neither of these studies made a distinction between activation of local granuloma macrophages and recuitment of fresh circulating monocytes. Differences in methodology preclude direct comparison between these in vivo studies and the present work. However, the demonstration that mouse lepromatous macrophages are refractory to Mu IFN--y activation suggests that a similar defect may exist in the macrophages found in the lesions of lepromatous leprosy in humans. Finally, since IFN--y appears to be the active molecule in MAF-containing T-cell supernatant media (22) , these studies suggest that it is important to focus on the macrophage-IFN--y interaction, as well as on T-cell deficiencies, in lepromatous leprosy. We are presently examining whether these granuloma macrophages lack the ability to receive the activating signal or whether they have a defect in their microbicidal mechanisms.
